Inside FDA’s VQIP, the program that expedites entry for proven, low-risk importers.
Ashish R. Talati
Advertisement
Ashish R. Talati is one of the industry’s foremost experts on FDA regulatory matters. He has gained an exceptional reputation for his successful results at the cutting edge of FDA and regulatory law, where he has responded nimbly to changes in the regulatory climate and the marketplace, guiding clients through some of our industries’ most complex issues.
Articles by Ashish R. Talati
What food and dietary supplement brands need to know about extended producer responsibility (EPR).
HHS and FDA consider major changes amid legal and industry pushback.
What do the new "healthy" label claim definitions mean for consumers and food brands?
Australia’s regulatory approach to botanical ingredient changes may inform U.S. companies as they prepare NDI draft guidance comments.
Advertisement
Latest Updated Articles
The GRAS system at a crossroadsPublished: April 10th 2025 | Updated:
Consulting Our Mates Down Under for NDI GuidancePublished: September 1st 2016 | Updated:
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
How GC Rieber VivoMega is adapting fish and algal omega-3 production to a changing market
2
Gluten labeling under review: GFCO on FDA’s Request for Information
3
The role of B6, B12, and folate in one-carbon metabolism and SAMe synthesis
4
Supporting thyroid health with iron
5